Elevance Health, Inc. (A58)
XETR
343.00
+4.50 (+1.33%)
Closed
Oct 2, 2026
Day's Range
338.70343.00
52 wk Range
241.60379.10
Financial Statements - A58 - Elevance Health, Inc.
Revenue
199.12B▲ 34.7%
Net Income
5.66B▲ 13.4%Net Margin 2.8%
Free Cash Flow
3.17B▼ 16.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|
| Sales | 199.12B | 147.86B | 156.59B | 138.63B | 121.86B | 104.21B |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 24.47B | 18.92B | 14.97B | 12.65B | 10.38B | - |
| Pre Tax Income | 6.71B | 6.61B | 7.76B | 7.92B | 6.23B | 5.98B |
| Income Tax | 1.04B | 1.61B | 1.75B | 1.83B | 1.66B | 1.17B |
| Net Income | 5.66B | 4.99B | 6.01B | 6.09B | 4.57B | 4.80B |
| EPS Basic | 25.651957 | 26.288061 | 25.1 | 25.04 | 18.23 | 18.81 |
| EPS Diluted | 25.21 | 25.68 | 24.81 | 24.73 | 17.98 | 18.47 |
| Basic Shares Outstanding | 220.72M | 190.23M | 240M | 243.80M | 250.80M | 255.50M |
| Diluted Shares Outstanding | 220.72M | 190.23M | 240M | 243.80M | 250.80M | 255.50M |
| Ebit | 8.11B | 7.60B | 8.62B | 8.72B | 7.02B | 6.73B |
| Ebitda | - | - | - | - | - | - |
| Net Income Continuous Operations | 5.66B | 4.99B | 6.01B | 6.09B | 4.57B | 4.80B |
| Minority Interests | 1M | 9M | 6M | 9M | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
